Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo

Shock

Volumn 31, Issue 3, 2009, Pages 280-284

  Van Zoelen, Marieke A D ^a,b,h   Yang, Huan ^c   Florquin, Sandrine ^d   Meijers, Joost C M ^b   Akira, Shizuo ^e   Arnold, Bernd ^f   Nawroth, Peter P ^g   Bierhaus, Angelika ^g   Tracev, Kevin J ^c   Van Poll, Tom Der ^a,b  

^a Center for Infection and Immunity Amsterdam   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d Departments of Pathology   (Netherlands)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

HMGB 1; Host defense; Receptor for advanced glycation end products; Sepsis; Toll like receptor 2; Toll like receptor 4

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; THROMBIN ANTITHROMBIN COMPLEX; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; ANTITHROMBIN III; ANTITHROMBIN III PROTEASE COMPLEX; ANTITHROMBIN III-PROTEASE COMPLEX; AUTACOID; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; PEPTIDE HYDROLASE; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENOTYPE; IN VIVO STUDY; INFLAMMATION; MOUSE; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PERITONEAL CAVITY; PERITONEUM LAVAGE; WILD TYPE; ANIMAL; CHEMICALLY INDUCED DISORDER; GENETICS; MALE; METABOLISM; MORTALITY; MOUSE MUTANT; PATHOLOGY; TIME;

ANIMALS; ANTITHROMBIN III; CYTOKINES; FEMALE; HMGB1 PROTEIN; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, KNOCKOUT; NEUTROPHILS; PEPTIDE HYDROLASES; RECEPTORS, IMMUNOLOGIC; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 62449255580     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318186262d     Document Type: Article

References (17)

1. Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331-342, 2005.
2. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al.: HMG-1 As a late mediator of endotoxin lethality in mice. Science 285:248-251, 1999.
3. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, et al.: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101:296-301, 2004.
4. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ, Lee ML, Andersson J, Tokics L, Treutiger CJ: Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 33:564-573, 2005.
5. van Zoelen MA, Laterre PF, van Veen SQ, van Till JW, Wittebole X, Bresser P, Tanck MW, Dugernier T, Ishizaka A, Boermeester MA, van der Poll T: Systemic and local high mobility group box 1 concentrations during severe infection. Crit Care Med 35:2799-2804, 2007.
6. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E: Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279:7370-7377, 2004.
7. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ, Yang H: HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26:174-179, 2006.
8. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, et al.: High mobility group box 1 protein interacts with multiple toll-like receptors. Am J Physiol Cell Physiol 290.-C917-C924, 2006.
9. Li J, Wang H, Mason JM, Yu M, Ulloa L, Czura CJ, Tracey KJ, Yang H: Recombinant HMGB1 with cytokine-stimulating activity. J Immunol Methods 289:211-213, 2004.
10. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S: Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451, 1999.
11. Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, Hofer S, Plachky J, Grone HJ, Kurschus FC, Schmidt AM, et al.: Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113:1641-1650, 2004.
12. Aida J, Pabst MJ: Priming of neutrophils by lipopolysaccharide for enhanced release of superoxide. Requirement for plasma but not for tumor necrosis factor-alpha. J Immunol 145:3017-3025, 2000.
13. Renckens R, Roelofs JJ, ter Horst SA, van't Veer C, Havik SR, Florquin S, Wagenaar GT, Meijers JC, van der Poll T: Absence of thrombin-activatable fibrinolysis inhibitor protects against sepsis-induced liver injury in mice. J Immunol 175:6764-6771, 2005.
14. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, Kobayashi A, Maruyama I, Yamada S, Hasegawa N, et al.: Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 170:1310-1316, 2004.
15. Izuishi K, Tsung A, Jeyabalan G, Critchlow ND, Li J, Tracey KJ, Demarco RA, Lotze MT, Fink MP, Geller DA, et al.: Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J Immunol 176:7154-7158, 2006.
16. Kokkola R, Andersson A, Mullins G, Ostberg T, Treutiger CJ, Arnold B, Nawroth P, Andersson U, Harris RA, Harris HE: RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 61:1-9, 2005.
17. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, et al.: Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8:487-496, 2007.